# US 2025/0367226 A1 · Anti-malassezia agent

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0367226 A1
- Document ID: US20250367226A1
- Status: Published application
- Kind: A1
- Application number: 19/223,384
- Filed: 2025-05-30
- Published: 2025-12-04
- Earliest claimed: 2024-06-03
- Assignees: NTH, Inc.
- Applicants: N.T.H Co., Ltd.
- Inventors: Yoshimi ODA; Souichi NAKASHIMA
- Web page: https://patentgrep.com/patent/US20250367226A1

## CPC

- A61K 31/7034: attached to a carbocyclic compound, e.g. phloridzin
- A61K 31/7048: having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin {, digitoxin or digoxin}
- A61K 36/185: Magnoliopsida (dicotyledons)
- A61P 31/10: Antimycotics
- C07H 15/203: Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems
- A61K 2236/331: using water, e.g. cold water, infusion, tea, steam distillation or decoction
- A61K 2236/333: using mixed solvents, e.g. 70% EtOH
- A61K 2236/51: Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)

## Abstract

Problem to be Solved: To provide an anti-Malassezia agent and a method for producing an active ingredient of the anti-Malassezia agent. Solution to the Problem: Provided is an anti-Malassezia agent comprising any one of compounds (I), (II) and (III) represented by the following formulas (I), (II) and (III): respectively, or a pharmaceutically acceptable salt thereof, or a henna extract. A method for producing the compound (I) is also provided. Selected Figure: none.

## Claims

### Claim 1

A method for inhibiting proliferation of Malassezia in a subject, comprising administering, to the subject, a compound (I) represented by the following formula (I):
a compound (II) represented by the following formula (II):
or
a compound (III) represented by the following formula (III):
or
a pharmaceutically acceptable salt, ether derivative or ester derivative of the compound (I), the compound (II) or the compound (III).

### Claim 2 (depends on 1)

The method according to claim 1, wherein the subject is a mammal.

### Claim 3 (depends on 2)

The method according to claim 2, wherein the mammal is a human.

### Claim 4 (depends on 1)

The method according to claim 1, wherein the administering is parenterally or orally administering.

### Claim 5 (depends on 1)

The method according to claim 1, wherein the administering is application to a skin of the subject.

### Claim 6

A method for inhibiting proliferation of Malassezia in a subject, comprising administering a henna extract to the subject.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the henna extract comprises at least one of compounds (I), (II) and (III) represented by the following formulas (I), (II) and (III):
respectively, or a pharmaceutically acceptable salt thereof.

### Claim 8 (depends on 6)

The method according to claim 6, wherein the henna extract is a henna leaf extract.

### Claim 9 (depends on 6)

The method according to claim 6, wherein the subject is a mammal.

### Claim 10 (depends on 9)

The method according to claim 9, wherein the mammal is a human.

### Claim 11 (depends on 6)

The method according to claim 6, wherein the administering is parenterally or orally administering.

### Claim 12 (depends on 6)

The method according to claim 6, wherein the administering is application to a skin of the subject.

### Claim 13

A method for producing a compound (I) represented by the following formula (I):
or
a pharmaceutically acceptable salt thereof, comprising
subjecting henna leaves to extraction to prepare an extract, and
obtaining the compound from the extract.
